<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Interleukin-1 beta (IL-1 beta) converting enzyme (ICE) cleaves pro-IL-1 beta to produce mature IL-beta, and is a member of a family of proteases implicated in <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>Intracerebroventricular (i.c.v.) administration of an irreversible ICE inhibitor, z-VAD-DCB (1 pmol, 30 min before and 15 min, 2, 4, 6 and 8 h after surgery) markedly reduced (50 +/- 4%, p &lt; 0.001) <z:mpath ids='MPATH_124'>infarct</z:mpath> volume measured 24 h after focal <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> (middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, MCAo) in the rat </plain></SENT>
<SENT sid="2" pm="."><plain>Inhibition of damage was observed in the cortex (51 +/- 5% reduction) and striatum (42 +/- 6% reduction) </plain></SENT>
<SENT sid="3" pm="."><plain>These data implicate ICE in ischaemic neuronal <z:hpo ids='HP_0011420'>death</z:hpo> in vivo </plain></SENT>
<SENT sid="4" pm="."><plain>Inhibition of ICE could reduce ischaemic damage either by preventing IL-1 beta synthesis or by inhibiting <z:mpath ids='MPATH_3'>apoptosis</z:mpath> or by both of these processes, and may provide a useful therapeutic approach to the inhibition of ischaemic brain damage </plain></SENT>
</text></document>